Skip to main content

Day: March 24, 2025

SKYX Reports 48% Revenue Growth in 2024 — From $58.8 Million in 2023 to $86.3 Million in 2024

Sales of SKYX’s Advanced and Smart Home Related Products Surge Over 1,000%; SKYX Expects its products to be in 20,000 Units/Homes by Q1 2025 and an Additional Tens of Thousands of Units/Homes in 2025 Company Expects Significant Projects and Orders and to Become Cash Flow Positive in Second Half of 2025 SKYX Achieves Revenue Growth in Four Consecutive Quarters for 2024Q1: $19M | Q2: $21M | Q3: $22.2M | Q4: $23.7M Record Sales SKYX’s Safety Code Standardization Team Anticipates Support from Additional Safety Organizations and Leading Members for a Safety Mandatory Standardization of its Ceiling Technology MIAMI, March 24, 2025 (GLOBE NEWSWIRE) — SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), an award winning highly disruptive advanced and smart home platform technology company with over 97...

Continue reading

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Positive Phase 1 Trial Data in Non-Muscle Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress; Supports Front-Line Treatment Potential Clinical Pipeline Continues to Advance with Phase 3 CoMpass Trial Actively Enrolling Phase 2 Trial in Metastases to the Choroid Initiated Cash Position Expected to Support Operations into 2H 2026 BOSTON, Mass., March 24, 2025 (GLOBE NEWSWIRE) — Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today reported financial results for the fourth quarter and year ended December 31, 2024, and provided recent business highlights. “We believe that bel-sar has the potential to transform the treatment paradigm in multiple rare oncology indications...

Continue reading

Acutus Medical Reports Full Year 2024 Financial Results

CARLSBAD, Calif., March 24, 2025 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the full year of 2024. Recent Highlights:2024 Revenue from Continuing Operations of $20.2 million grew 181% year-over-year, from $7.2 million last year. Operating loss for continuing operations was $0.1 million, compared to 11.7 million last year. Recorded $10.8 million in gain on sale of business, an increase of 19% compared to last year. Cash, cash equivalents, marketable securities and restricted cash were $14.0 million as of December 31, 2024.Full Year 2024 Financial ResultsRevenue from Continuing Operations was $20.2 million for 2024, an increase of 181% compared to $7.2 million in 2023. Gross margin on a GAAP basis for continuing operations was 5% for 2024 compared to negative 44%...

Continue reading

HII Tops 700 REMUS Uncrewed Underwater Vehicles Sold, Strengthening America’s Undersea Advantage

MCLEAN, Va., March 24, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII), America’s largest shipbuilder and all-domain technologies and solutions provider, has sold more than 700 REMUS uncrewed underwater vehicles (UUVs) to customers globally, delivering the undersea advantage and expanding HII’s lead as the world’s largest producer. “HII’s investment in advanced undersea autonomy is yielding promising returns, most notably in demonstrating to our customers how this technology can be integrated to support their evolving and critical mission needs,” HII President and CEO Chris Kastner said. “From mine countermeasures to anti-submarine warfare, REMUS continues to safeguard strategic waterways and enhance maritime security for the U.S. and its allies. The platform’s longevity and adaptability reflect HII’s dedication to providing reliable,...

Continue reading

PowerPlan Announces NXT: 30 Years of Industry Expertise, Now Powered by AI

PowerPlan NXTOptimize financial outcomes with AI-powered tax and accounting solutionsATLANTA, March 24, 2025 (GLOBE NEWSWIRE) — PowerPlan, Inc., a leading provider of financial software solutions for the energy industry, today announced PowerPlan NXT at its 2025 ELEVATE user conference in Atlanta. The new SaaS platform empowers tax and accounting professionals to optimize financial assets throughout their lifecycle. Purpose-built for asset-intensive companies, NXT integrates operational and financial data to facilitate specialized accounting treatments, accommodate complex tax requirements, and support rate-making processes. “NXT is the next-generation tax and accounting solution that organizations need to tackle complex financial challenges with confidence,” said Todd Bransford, Chief Product Officer, PowerPlan. “It includes...

Continue reading

Verizon to speak at New Street Research Conference on March 26

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) — Frank Boulben, senior vice president and chief revenue officer for the Consumer Group of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the New Street Research and BCG Future of Connectivity Leaders Conference on Wednesday, March 26, at 8:30 a.m. ET. His remarks will be webcast, with access instructions available on Verizon’s Investor Relations website, www.verizon.com/about/investors. Boulben will discuss the unit’s progress to innovate on its mobile and broadband platforms, bringing differentiated offers to the market and enhancing its value proposition, while elevating the customer experience and strengthening customer relationships. Verizon is on track to deliver on its full-year 2025 financial and operational guidance and remains committed to its three key priorities of growing...

Continue reading

Davis Commodities Announces Issuance of New Shares Amounting to USD 30 Million

SINGAPORE, March 24, 2025 (GLOBE NEWSWIRE) — Davis Commodities Limited (NASDAQ: DTCK) is pleased to announce its decision to issue new shares amounting to USD 30 million, marking a strategic move to fuel the company’s growth and expansion initiatives. Benefits of the New Share Issue: The issuance of new shares will provide Davis Commodities with a significant influx of capital, enabling the company to pursue various strategic opportunities aimed at enhancing operational efficiency, driving revenue growth, and expanding its market presence. Utilization of New Funds: The proceeds from the new share issue will be allocated towards several key areas to further strengthen Davis Commodities’ position in the global market:Mergers and Acquisitions (M&A): Davis Commodities will explore potential M&A opportunities...

Continue reading

Brompton Funds Declares Distribution

TORONTO, March 24, 2025 (GLOBE NEWSWIRE) — (TSX: CLSA) Brompton Funds announces a distribution in the amount of Cdn$0.10 per unit to unitholders of Brompton Split Corp. Class A Share ETF for the following record date:Record Date Payment DateMarch 31, 2025 April 14, 2025The current monthly distribution represents an annualized distribution of 12% based on the initial issue price of $10.00. About Brompton FundsFounded in 2000, Brompton is an experienced investment fund manager with income and growth focused investment solutions including TSX traded closed-end funds and exchange-traded funds. For further information, please contact your investment advisor, call Brompton’s investor relations line at 416-642-6000 (toll-free at 1-866-642-6001), email info@bromptongroup.com or visit our website at www.bromptongroup.com. Commissions,...

Continue reading

Spineway : Consolidated 2024 annual results – Operating income close to breakeven

Press release         Ecully, March 24, 2025 – 6 p.m.SPINEWAY Consolidated 2024 annual resultsAnnual revenue of €12 million (+14%) Operating income close to breakeven Reduction in net lossIn thousands of euros Consolidated accounts 2024 2023Revenue 11,950 10,519Cost of sales (3,699) (3,309)Gross margin % of revenue 8,250 69% 7,210 69%Net operating expenses Of which running costs (9,131) (3,900) (11,727) (5,424)Of which personnel expenses (4,890) (5,659)Operating income/(loss) (881) (4,517)Financial income/(expense) Including the Negma exceptional financial expense1 (2,464) (1,467) (1,035) /Non-recurring income/(expenses) (514) (957)Net income/(loss) Of which adjusted net income/(loss) (3,859) (2,392) (6,510) (6,510)The Board of Directors of Spineway, meeting on March 24, 2025 under the chairmanship...

Continue reading

Annual General Meeting to be held on Tuesday 29 April 2025 and 2024 Universal Registration Document

L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Tuesday 29 April 2025 and the 2024 Universal Registration Document. TERMS OF INFORMATION AVAILABILITY REGARDING THE ANNUAL GENERAL MEETING OF TUESDAY 29 APRIL 2025 The Annual General Meeting of L’Oréal (hereafter the “Company”) will be held on Tuesday 29 April 2025 at 10 a.m. (Paris time) at Le Palais des Congrès de Paris (2, place de la Porte Maillot, 75017 Paris). The meeting notice was published in the BALO (Bulletin des Annonces Légales Obligatoires) on Monday 24 March 2025 and includes the agenda, the draft resolutions and the main terms of participation and voting at this General Meeting. The meeting notice, the Board of Directors’ Report on the draft resolutions and legal information...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.